References
- Kiechle F L. DNA technology in the clinical laboratory. Arch Pathol Lab Med 1999; 123: 1151–1153
- Hosler G A, Bash R O, Bai X, Jain V, Scheuermann R H. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am J Pathol 1999; 154: 1023–1035
- Sabath D E, Wood B L, Kussick S J. PCR methods for determining B cell clonality. J Mol Diagn 2000; 2: 217–218
- Hodges E, Williams A P, Harris S, Smith J L. T-cell receptor molecular diagnosis of T-cell lymphoma. Methods Mol Med 2005; 115: 197–215
- Miller J E, Wilson S S, Jaye D L, Kronenberg M. An automated semiquantitative B and T cell clonality assay. Mol Diagn 1999; 4: 101–117
- Devlin B H, Ratech H, Kaufman R. Inclusion of a sensitivity control to add a quality-control parameter and improve reproducibility in BCR, immunoglobulin, and T-cell receptor gene-rearrangement studies. Diagn Mol Pathol 1994; 3: 271–274
- Yao R, Rich S A, Schneider E. Validation of sixteen leukemia and lymphoma cell lines as controls for molecular gene rearrangement assays. Clin Chem 2002; 48: 1344–1351
- van Dongen J J, Langerak A W, Bruggemann M, Evans P A, Hummel M, Lavender F L, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
- Eckert C, Scrideli C A, Taube T, Songia S, Wellmann S, Manenti M, et al. Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes. Leukemia 2003; 17: 2517–2524
- Droese J, Langerak A W, Groenen P J, Bruggemann M, Neumann P, Wolvers-Tettero I L, et al. Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia 2004; 18: 1531–1538
- Matthews C, Catherwood M, Morris T C, Alexander H D. Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma 2004; 45: 1899–1904
- McClure R F, Kaur P, Pagel E, Ouillette P D, Holtegaard C E, Treptow C L, et al. Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers. Leukemia 2006; 20: 176–179
- Lassmann S, Gerlach U V, Technau-Ihling K, Werner M, Fisch P. Application of BIOMED-2 Primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas. J Mol Diagn 2005; 7: 582–591
- Sandberg Y, van Gastel-Mol E J, Verhaaf B, Lam K H, van Dongen J J, Langerak A W. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. J Mol Diagn 2005; 7: 495–503
- Lukowsky A, Marchwat M, Sterry W, Gellrich S. Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma 2006; 47: 487–493